Skip to main content
Michael Madigan, MD, Vascular Surgery, Pittsburgh, PA

Michael Charles Madigan MD


Physician

Join to View Full Profile
  • 200 Lothrop StPittsburgh, PA 15213

  • Phone+1 412-802-3333

Dr. Madigan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • UPMC Medical Education (Pittsburgh)
    UPMC Medical Education (Pittsburgh)Residency, Surgery, 2007 - 2014
  • Vanderbilt University School of Medicine
    Vanderbilt University School of MedicineClass of 2007

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 2007 - 2026
  • Surgery
    American Board of Surgery Surgery
  • Vascular Surgery
    American Board of Surgery Vascular Surgery

Awards, Honors, & Recognition

  • Fellow (FACS) American College of Surgeons

Publications & Presentations

PubMed

Journal Articles

  • Nationwide Trends in Drug-Coated Balloon and Drug-Eluting Stent Utilization in the Femoropopliteal Arteries  
    Abhisekh Mohapatra, Daniel J Bertges, Michael C Madigan, Georges E Al-Khoury, Mohammad H Eslami, Journal of Vascular Surgery
  • Occult Type I or III Endoleaks Are a Common Cause of Failure of Type II Endoleak Treatment After Endovascular Aortic Repair  
    Michael C Madigan, Michael J Singh, Rabih A Chaer, Georges E Al-Khoury, Journal of Vascular Surgery

Authored Content

  • Nationwide Trends in Drug-Coated Balloon and Drug-Eluting Stent Utilization in the Femoropopliteal ArteriesJuly 2018
  • Increasing Use of Open Conversion for Late Complications After Endovascular Aortic Aneurysm RepairJanuary 2018
  • Increasing Use of Open Conversion for Late Complications After Endovascular Aortic Aneurysm RepairJanuary 2018
  • Occult Type I or III Endoleaks Are a Common Cause of Failure of Type II Endoleak Treatment After Endovascular Aortic RepairDecember 2017
  • Join now to see all

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: